CV Sciences, Inc. (CVSI) stock
CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-21.13%)
Close on Oct 19, 2026Market cap $2.53MP/E –Yield –
CV Sciences gross margin
Gross margin is gross profit as a percentage of revenue.
CV Sciences's gross margin for the twelve months ending Sep 30, 2026 was 49.5%. For fiscal 2025 it was 49.0%, against 45.6% the year before. The highest annual figure on record is 70.2% in fiscal 2018.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 49.0% | +3.3 |
| FY2024 | Dec 31, 2024 | 45.6% | +1.4 |
| FY2023 | Dec 31, 2023 | 44.3% | +10.0 |
| FY2022 | Dec 31, 2022 | 34.2% | −8.7 |
| FY2021 | Dec 31, 2021 | 43.0% | −2.1 |
| FY2020 | Dec 31, 2020 | 45.1% | −20.3 |
| FY2019 | Dec 31, 2019 | 65.3% | −4.9 |
| FY2018 | Dec 31, 2018 | 70.2% | +0.2 |
| FY2017 | Dec 31, 2017 | 70.1% | +6.8 |
| FY2016 | Dec 31, 2016 | 63.3% | +4.9 |
| FY2015 | Dec 31, 2015 | 58.4% | +1.4 |
| FY2014 | Dec 31, 2014 | 57.0% | −2.2 |
| FY2013 | Dec 31, 2013 | 59.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 50.0% | +1.5 |
| Q2 FY2026 | Jun 30, 2026 | 48.6% | −2.4 |
| Q1 FY2026 | Mar 31, 2026 | 48.9% | +2.9 |
| Q4 FY2025 | Dec 31, 2025 | 50.5% | +7.4 |
| Q3 FY2025 | Sep 30, 2025 | 48.5% | +2.5 |
| Q2 FY2025 | Jun 30, 2025 | 50.9% | +3.9 |
| Q1 FY2025 | Mar 31, 2025 | 46.0% | −0.3 |
| Q4 FY2024 | Dec 31, 2024 | 43.2% | −2.7 |
| Q3 FY2024 | Sep 30, 2024 | 46.0% | +0.9 |
| Q2 FY2024 | Jun 30, 2024 | 47.0% | +3.7 |
| Q1 FY2024 | Mar 31, 2024 | 46.3% | +3.3 |
| Q4 FY2023 | Dec 31, 2023 | 45.8% | +5.5 |
| Q3 FY2023 | Sep 30, 2023 | 45.1% | +3.4 |
| Q2 FY2023 | Jun 30, 2023 | 43.3% | +12.6 |
| Q1 FY2023 | Mar 31, 2023 | 43.0% | +17.0 |
| Q4 FY2022 | Dec 31, 2022 | 40.4% | +8.0 |
| Q3 FY2022 | Sep 30, 2022 | 41.6% | −4.5 |
| Q2 FY2022 | Jun 30, 2022 | 30.7% | −14.0 |
| Q1 FY2022 | Mar 31, 2022 | 26.0% | −22.7 |
| Q4 FY2021 | Dec 31, 2021 | 32.4% | −10.3 |
| Q3 FY2021 | Sep 30, 2021 | 46.2% | +2.0 |
| Q2 FY2021 | Jun 30, 2021 | 44.7% | +1.6 |
| Q1 FY2021 | Mar 31, 2021 | 48.7% | +0.2 |
| Q4 FY2020 | Dec 31, 2020 | 42.7% | −1.8 |
| Q3 FY2020 | Sep 30, 2020 | 44.2% | −22.7 |
| Q2 FY2020 | Jun 30, 2020 | 43.0% | −27.9 |
| Q1 FY2020 | Mar 31, 2020 | 48.5% | −22.3 |
| Q4 FY2019 | Dec 31, 2019 | 44.5% | −21.0 |
| Q3 FY2019 | Sep 30, 2019 | 66.9% | −6.3 |
| Q2 FY2019 | Jun 30, 2019 | 70.9% | −2.5 |
| Q1 FY2019 | Mar 31, 2019 | 70.8% | +1.9 |
| Q4 FY2018 | Dec 31, 2018 | 65.5% | −6.5 |
| Q3 FY2018 | Sep 30, 2018 | 73.1% | +1.6 |
| Q2 FY2018 | Jun 30, 2018 | 73.4% | +3.7 |
| Q1 FY2018 | Mar 31, 2018 | 68.9% | +4.3 |
| Q4 FY2017 | Dec 31, 2017 | 72.0% | +15.3 |
| Q3 FY2017 | Sep 30, 2017 | 71.5% | – |
| Q2 FY2017 | Jun 30, 2017 | 69.7% | – |
| Q1 FY2017 | Mar 31, 2017 | 64.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 56.7% | – |
See a number that looks wrong?